Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roblin

Showing results (661-670 of 756) with videos related to

Pageof 76
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Fluke-borne viruses are a risk factor for diseases caused by carcinogenic trematodesSujittra Chaiyadet, Tom Roblin, Anais Fauchois, et al.
Iscience|September 4, 2023
Mechanistic and functional aspects of the Ruminococcin C sactipeptide isoformsLama Shamseddine, Clarisse Roblin, Iris Veyrier, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2017
The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trialF D Wolinsky, S F Hall, Y Lou, et al.
Pharmacoepidemiology and Drug Safety|January 17, 2009
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerationsJeffrey S Brown, Martin Kulldorff, Kenneth R Petronis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Pediatrics|April 18, 2018
Mental Health of Transgender and Gender Nonconforming Youth Compared With Their PeersTracy A Becerra-Culqui, Yuan Liu, Rebecca Nash, et al.
Pageof 76

Showing results (661-670 of 756) with videos related to

Sort By:
Pageof 76
Biorxiv : the Preprint Server for Biology|November 24, 2025
Fluke-borne viruses are a risk factor for diseases caused by carcinogenic trematodesSujittra Chaiyadet, Tom Roblin, Anais Fauchois, et al.
Iscience|September 4, 2023
Mechanistic and functional aspects of the Ruminococcin C sactipeptide isoformsLama Shamseddine, Clarisse Roblin, Iris Veyrier, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2017
The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trialF D Wolinsky, S F Hall, Y Lou, et al.
Pharmacoepidemiology and Drug Safety|January 17, 2009
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerationsJeffrey S Brown, Martin Kulldorff, Kenneth R Petronis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Pediatrics|April 18, 2018
Mental Health of Transgender and Gender Nonconforming Youth Compared With Their PeersTracy A Becerra-Culqui, Yuan Liu, Rebecca Nash, et al.
Pageof 76